Regulatory Approvals

Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’

By

Regulatory Approvals — Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’  Pharmaceutical Technology

Read the original at Regulatory Approvals ↗

Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. August 20, 2026.

By

Related Post

Regulatory Approvals

Would you let a robot draw your blood? FDA approves new medical tech

Regulatory Approvals

FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva

Regulatory Approvals

FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth

Financial News For All

Litigation

Prediction market firm sues Kaul to prevent enforcement of Wisconsin gambling law

Mergers & Acquisitions

Report warns Paramount-Warner merger could erase 4,500 jobs in L.A.

Mergers & Acquisitions

Could the Dominion-NextEra merger inspire the General Assembly to expand the State Corporation Commission? The constitution allows it.

Mergers & Acquisitions

Decision On Paramount’s $1.88B Merger Bond Now Close To Ticking Fee Start Date